Long Term Debt Summary of Mayinglong Pharmaceutical Group Co., LTD.

Mayinglong Pharmaceutical Group Co., LTD.'s latest annual long term debt in 2023 was 128.45 Million CNY , down -75.39% from previous year.
Mayinglong Pharmaceutical Group Co., LTD.'s latest quarterly long term debt in 2024 Q1 was 99.9 Million CNY , down -0.1% from previous quarter.
Mayinglong Pharmaceutical Group Co., LTD. reported annual long term debt of 521.99 Million CNY in 2022, up 613.03% from previous year.
Mayinglong Pharmaceutical Group Co., LTD. reported annual long term debt of 73.2 Million CNY in 2021, up 587.81% from previous year.
Mayinglong Pharmaceutical Group Co., LTD. reported quarterly long term debt of 109.7 Million CNY for 2024 Q2, up 9.81% from previous quarter.
Mayinglong Pharmaceutical Group Co., LTD. reported quarterly long term debt of 99.9 Million CNY for 2024 Q1, down -0.1% from previous quarter.

Annual Long Term Debt Chart of Mayinglong Pharmaceutical Group Co., LTD. (2023 - 2001)

Historical Annual Long Term Debt of Mayinglong Pharmaceutical Group Co., LTD. (2023 - 2001)

Year	Long Term Debt	Long Term Debt Growth
2023	128.45 Million CNY	-75.39%
2022	521.99 Million CNY	613.03%
2021	73.2 Million CNY	587.81%
2020	10.64 Million CNY	112.87%
2019	5 Million CNY	100.0%
2018	2.5 Million CNY	-33.33%
2017	3.75 Million CNY	-25.0%
2016	5 Million CNY	499999901.86%
2015	1.00 CNY	0.0%
2014	- CNY	0.0%
2013	- CNY	0.0%
2012	- CNY	0.0%
2011	- CNY	0.0%
2010	- CNY	0.0%
2009	- CNY	0.0%
2008	- CNY	0.0%
2007	- CNY	0.0%
2006	- CNY	-100.0%
2005	10 Million CNY	0.0%
2004	- CNY	-100.0%
2003	5.3 Million CNY	0.0%
2002	- CNY	0.0%
2001	- CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q3	80.61 Million CNY	-100.0%
2024 Q2	109.7 Million CNY	9.81%
2024 Q1	99.9 Million CNY	-0.1%
2023 FY	128.45 Million CNY	-75.39%
2023 Q1	529.71 Million CNY	1.48%
2023 Q4	193.58 Million CNY	-62.34%
2023 Q2	516.26 Million CNY	-2.54%
2023 Q3	514.09 Million CNY	-0.42%
2022 Q1	71.77 Million CNY	-1.96%
2022 FY	521.99 Million CNY	613.03%
2022 Q4	521.99 Million CNY	-1.84%
2022 Q3	531.76 Million CNY	707.49%
2022 Q2	65.85 Million CNY	-8.25%
2021 Q2	65.12 Million CNY	0.0%
2021 Q1	65.12 Million CNY	511.85%
2021 FY	73.2 Million CNY	587.81%
2021 Q3	84.65 Million CNY	30.0%
2021 Q4	73.2 Million CNY	-13.53%
2020 Q1	5 Million CNY	0.0%
2020 Q3	5 Million CNY	0.0%
2020 FY	10.64 Million CNY	112.87%
2020 Q2	5 Million CNY	0.0%
2020 Q4	10.64 Million CNY	112.87%
2019 Q2	2.5 Million CNY	0.0%
2019 FY	5 Million CNY	100.0%
2019 Q4	5 Million CNY	100.0%
2019 Q3	2.5 Million CNY	0.0%
2019 Q1	2.5 Million CNY	0.0%
2018 Q2	3.75 Million CNY	0.0%
2018 FY	2.5 Million CNY	-33.33%
2018 Q1	3.75 Million CNY	0.0%
2018 Q3	3.75 Million CNY	0.0%
2018 Q4	2.5 Million CNY	-33.33%
2017 FY	3.75 Million CNY	-25.0%
2017 Q2	5 Million CNY	0.0%
2017 Q3	5 Million CNY	0.0%
2017 Q4	3.75 Million CNY	-25.0%
2017 Q1	5 Million CNY	0.0%
2016 Q2	- CNY	0.0%
2016 Q3	- CNY	0.0%
2016 FY	5 Million CNY	499999901.86%
2016 Q1	- CNY	-100.0%
2016 Q4	5 Million CNY	0.0%
2015 Q4	1.00 CNY	0.0%
2015 FY	1.00 CNY	0.0%
2015 Q2	- CNY	0.0%
2015 Q1	- CNY	0.0%
2015 Q3	- CNY	0.0%
2014 FY	- CNY	0.0%
2014 Q4	- CNY	0.0%
2014 Q3	- CNY	0.0%
2014 Q2	- CNY	0.0%
2014 Q1	- CNY	0.0%
2013 Q4	- CNY	0.0%
2013 Q1	- CNY	0.0%
2013 Q2	- CNY	0.0%
2013 Q3	- CNY	0.0%
2013 FY	- CNY	0.0%
2012 Q2	- CNY	0.0%
2012 Q1	- CNY	0.0%
2012 Q3	- CNY	0.0%
2012 Q4	- CNY	0.0%
2012 FY	- CNY	0.0%
2011 Q4	- CNY	0.0%
2011 Q1	- CNY	0.0%
2011 Q2	- CNY	0.0%
2011 FY	- CNY	0.0%
2011 Q3	- CNY	0.0%
2010 Q3	- CNY	0.0%
2010 FY	- CNY	0.0%
2010 Q2	- CNY	0.0%
2010 Q1	- CNY	0.0%
2010 Q4	- CNY	0.0%
2009 Q4	- CNY	0.0%
2009 FY	- CNY	0.0%
2009 Q3	- CNY	0.0%
2009 Q2	- CNY	0.0%
2009 Q1	- CNY	0.0%
2008 Q4	- CNY	0.0%
2008 Q2	- CNY	0.0%
2008 Q1	- CNY	0.0%
2008 Q3	- CNY	0.0%
2008 FY	- CNY	0.0%
2007 Q3	- CNY	0.0%
2007 Q2	- CNY	-100.0%
2007 FY	- CNY	0.0%
2007 Q1	14 Million CNY	0.0%
2007 Q4	- CNY	0.0%
2006 Q3	- CNY	-100.0%
2006 Q4	- CNY	0.0%
2006 FY	- CNY	-100.0%
2006 Q2	10 Million CNY	0.0%
2006 Q1	10 Million CNY	0.0%
2005 Q1	- CNY	0.0%
2005 Q3	- CNY	0.0%
2005 FY	10 Million CNY	0.0%
2005 Q2	- CNY	0.0%
2005 Q4	10 Million CNY	0.0%
2004 FY	- CNY	-100.0%
2004 Q3	300 Thousand CNY	-94.34%
2004 Q2	5.3 Million CNY	0.0%
2004 Q4	- CNY	-100.0%
2003 Q4	5.3 Million CNY	0.0%
2003 FY	5.3 Million CNY	0.0%
2002 FY	- CNY	0.0%
2001 FY	- CNY	0.0%

Peer Long Term Debt Comparison of Mayinglong Pharmaceutical Group Co., LTD.

Name	Long Term Debt	Long Term Debt Difference
Shanghai Haoyuan Chemexpress Co., Ltd.	229.23 Million CNY	43.961%
Hubei Jumpcan Pharmaceutical Co., Ltd.	1.43 Million CNY	-8855.458%
Yabao Pharmaceutical Group Co., Ltd	3.36 Million CNY	-3712.761%
Shandong Lukang Pharmaceutical Co.,Ltd.	1.3 Billion CNY	90.186%
Zhejiang Huahai Pharmaceutical Co., Ltd.	4.02 Billion CNY	96.806%
Tasly Pharmaceutical Group Co., Ltd	1.41 Billion CNY	90.909%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited	241.03 Million CNY	46.705%
Lionco Pharmaceutical Group Co.,Ltd.	445.18 Million CNY	71.145%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.	70.75 Million CNY	-81.562%
China Animal Husbandry Industry Co., Ltd.	899.03 Million CNY	85.711%
Jiangsu Kanion Pharmaceutical Co.,Ltd.	1.92 Million CNY	-6571.477%
Zhejiang Shengda Bio-Pharm Co., Ltd.	144 Million CNY	10.793%
Tianjin Tianyao Pharmaceuticals Co., Ltd.	277 Million CNY	53.625%
Henan Lingrui Pharmaceutical Co., Ltd.	6.96 Million CNY	-1745.113%
Guizhou Yibai Pharmaceutical Co., Ltd.	387.22 Million CNY	66.826%
Zhongzhu Healthcare Holding Co.,Ltd	12.76 Million CNY	-906.364%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	10.95 Million CNY	-1072.846%
Jianmin Pharmaceutical Group Co.,Ltd.	30.29 Million CNY	-324.036%
North China Pharmaceutical Company Ltd.	4.08 Billion CNY	96.852%
CanSino Biologics Inc.	1.07 Billion CNY	88.041%
Zhejiang Hisun Pharmaceutical Co., Ltd.	2.39 Billion CNY	94.642%
Heilongjiang ZBD Pharmaceutical Co., Ltd.	1.29 Billion CNY	90.104%
ChengDu ShengNuo Biotec Co.,Ltd.	189.19 Million CNY	32.102%
Dali Pharmaceuticalco.,Ltd	14.84 Million CNY	-765.071%
Harbin Pharmaceutical Group Co., Ltd.	32.62 Million CNY	-293.696%
Zhejiang Medicine Co., Ltd.	230.54 Million CNY	44.281%
HPGC Renmintongtai Pharmaceutical Corporation	29.4 Million CNY	-336.802%
Humanwell Healthcare (Group) Co.,Ltd.	1.65 Billion CNY	92.217%
Ginwa Enterprise (Group) Inc.	5.42 Million CNY	-2265.993%
KPC Pharmaceuticals, Inc.	107.56 Million CNY	-19.428%
Changchun BCHT Biotechnology Co.	-9.85 Million CNY	1403.322%
Jiangsu Jibeier Pharmaceutical Co., Ltd.	- CNY	-Infinity%
Ningbo Menovo Pharmaceutical Co., Ltd.	759.64 Million CNY	83.09%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd	389.05 Million CNY	66.981%
Nanjing Well Pharmaceutical Group Co.,Ltd.	104.06 Million CNY	-23.442%
Joincare Pharmaceutical Group Industry Co.,Ltd.	3.12 Billion CNY	95.886%
China Resources Double-Crane Pharmaceutical Co.,Ltd.	29.94 Million CNY	-328.916%
Chongqing Taiji Industry(Group) Co.,Ltd	341.6 Million CNY	62.395%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited	3.32 Billion CNY	96.135%
China National Medicines Corporation Ltd.	205.07 Million CNY	37.36%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.	316.84 Million CNY	59.458%
Shenzhen Chipscreen Biosciences Co., Ltd.	1.02 Billion CNY	87.442%
Beijing Tongrentang Co., Ltd	1.42 Billion CNY	91.015%
Tibet Weixinkang Medicine Co., Ltd.	3.81 Million CNY	-3263.826%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	13.5 Billion CNY	99.049%
Hunan Fangsheng Pharmaceutical Co., Ltd.	174 Million CNY	26.175%
Guangxi Wuzhou Zhongheng Group Co.,Ltd	553.47 Million CNY	76.791%
Shanghai Jiaoda Onlly Co.,Ltd	120.22 Million CNY	-6.846%
Jiang Zhong Pharmaceutical Co.,Ltd	1.04 Million CNY	-12161.035%
Guobang Pharma Ltd.	451.7 Million CNY	71.561%
Cisen Pharmaceutical Co., Ltd.	132.53 Million CNY	3.074%
Hunan Warrant Pharmaceutical Co.,Ltd	17.1 Million CNY	-650.94%
Shaanxi Kanghui Pharmaceutical Co., Ltd.	283.87 Million CNY	54.749%
Shandong Buchang Pharmaceuticals Co., Ltd.	2.09 Billion CNY	93.876%
Zhejiang Starry Pharmaceutical Co.,Ltd.	734.44 Million CNY	82.51%
Kangmei Pharmaceutical Co., Ltd.	188.16 Million CNY	31.73%
Henan Taloph Pharmaceutical Stock Co.,Ltd	183.8 Million CNY	30.11%
ZhuZhou QianJin Pharmaceutical Co.,Ltd	38.46 Million CNY	-233.981%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd	512.37 Million CNY	74.929%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.	40.62 Million CNY	-216.224%
Shanghai Shyndec Pharmaceutical Co., Ltd.	1.03 Billion CNY	87.54%
Shanghai Yizhong Pharmaceutical Co., Ltd.	- CNY	-Infinity%
Tibet Rhodiola Pharmaceutical Holding Co.	1.12 Million CNY	-11314.201%
Sichuan Huiyu Pharmaceutical Co., Ltd.	2.04 Million CNY	-6171.444%
Jiangsu Lianhuan Pharmaceutical Co., Ltd.	82.91 Million CNY	-54.933%

Global Stocks Search

Mayinglong Pharmaceutical Group Co., LTD. (600993.SS)

Long Term Debt Summary of Mayinglong Pharmaceutical Group Co., LTD.

Annual Long Term Debt Chart of Mayinglong Pharmaceutical Group Co., LTD. (2023 - 2001)

Historical Annual Long Term Debt of Mayinglong Pharmaceutical Group Co., LTD. (2023 - 2001)

Peer Long Term Debt Comparison of Mayinglong Pharmaceutical Group Co., LTD.